India Markets closed

Synthetic Biologics, Inc. (SYN)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.9116+0.0653 (+7.72%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.8463
Bid0.9300 x 1100
Ask0.9300 x 900
Day's range0.8500 - 0.9505
52-week range0.2500 - 1.7000
Avg. volume11,191,095
Market cap48.925M
Beta (5Y monthly)2.28
PE ratio (TTM)N/A
EPS (TTM)-0.7020
Earnings date10-Nov-2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est1.25
  • GlobeNewswire

    Sýn hf.: Q1 2020 affected by the COVID-19 pandemic

    Sýn hf.’s Condensed Consolidated Interim Financial Statements for Q1 2020 was approved by the board on May 13th, 2020. • Revenue for the first quarter (Q1) of 2020 amounted to ISK 4,995 million, on par with the same period in 2019. • The quarter’s EBITDA amounted to ISK 1,355 million, compared to ISK 1,260 million in the first quarter of 2019.

  • GlobeNewswire

    Results in line with outlook

    • Revenue for the fourth quarter of 2019 amounted to ISK 4,935 million, a decrease of 9% from the same period in 2018. • The quarter’s EBITDA amounted to ISK 1,409 million, compared to ISK 1,449 million in the fourth quarter of 2018. The EBITDA margin was 28.6% in the fourth quarter of 2019 compared to 26.7% in the same quarter last year.